A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Effectiveness of Vaccination and Previous Infection Against Omicron Infection and Severe Outcomes in Children Under 12 Years of Age | medRxiv
COVID-19 BIVALENT BOOSTER EFFECTIVENESS IN PEOPLE WITH AND WITHOUT IMMUNE DYSFUNCTION - CROI Conference
Bivalent mRNA booster effective, 'essential' for older adults
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a
Updated Bivalent Boosters Offer Extra Protection Against COVID-19
Potentially breaking the COVID-19 stalemate with variant booster, bivalent or polyvalent vaccines
A quick update on the bivalent boosters - by Eric Topol
Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study - The Lancet Infectious Diseases
Let's discuss COVID-19 Bivalent Booster Effectiveness - ICAP
DPH Shares Monthly COVID-19 Update, Announces Changes to Data Reporting and Booster Guidance - State of Delaware News
New Omicron-specific vaccines offer similar protection to existing boosters
What We Know About Getting a Second Booster Shot of COVID-19 Vaccines | The Scientist Magazine®
Eric Topol on X: "The BA.5 bivalent booster's effectiveness: by April 2023, "individuals previously vaccinated only with wild-type vaccines had little protection against Covid-19 hospital admission" restored by the booster (24K cases,
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study - The Lancet Infectious Diseases
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
COVID-19 Bivalent Boosters | Johns Hopkins | Bloomberg School of Public Health
CDC publishes first estimates of bivalent boosters' effectiveness against XBB.1.5
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine | Australian Government Department of Health and Aged Care
Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against Omicron severe outcomes among adults aged ≥50 years in Ontario, Canada | medRxiv
Effectiveness of Bivalent Boosters against Severe Omicron Infection | NEJM
NEJM on X: "Figure 1. Effectiveness of Bivalent Boosters According to the Interval since Administration. https://t.co/hIVtIujZoq #Covid19 https://t.co/KBljA6y7NR" / X
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 | MMWR
Why payers should be preparing now for new COVID-19 boosters
